Research Article

The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer

Table 2

Relationship between the clinical features of liver cancer and INPP5K expression.

ParameterVariablesHigh%Low%X2Fish

Age<5511766(29.46)51(34.46)0.81270.36730.3615
≥55255158(70.54)97(65.54)
GenderFemale12175(33.33)46(31.08)0.11660.73270.7346
Male252150(66.67)102(68.92)
Histological typeFibrolamellar carcinoma33(1.33)0(0)3.96050.1380.1695
Hepatocellular carcinoma363216(96)147(99.32)
Hepatocholangiocarcinoma (mixed)76(2.67)1(0.68)
Histologic gradeG15538(17.19)17(11.56)4.210.23970.2344
G2178110(49.77)68(46.26)
G312366(29.86)57(38.78)
G4127(3.17)5(3.4)
StageI172109(51.66)63(45.65)1.29960.72920.7014
II8751(24.17)36(26.09)
III8548(22.75)37(26.81)
IV53(1.42)2(1.45)
T classificationT1182115(51.57)67(45.27)2.28640.68320.7163
T29555(24.66)40(27.03)
T38045(20.18)35(23.65)
T4137(3.14)6(4.05)
TX11(0.45)0(0)
N classificationN0253150(66.96)103(69.59)0.53990.76340.6991
N142(0.89)2(1.35)
NX11572(32.14)43(29.05)
M classificationM0267159(70.67)108(72.97)0.49470.78090.7461
M142(0.89)2(1.35)
MX10264(28.44)38(25.68)
Radiation therapyNo340208(97.65)132(97.78)011
Yes85(2.35)3(2.22)
Residual tumorR0326198(90.41)128(87.07)2.75960.43020.4237
R1178(3.65)9(6.12)
R210(0)1(0.68)
RX2213(5.94)9(6.12)
Vital statusDeceased13068(30.22)62(41.89)4.85290.02760.0262
Living243157(69.78)86(58.11)
Sample typePrimary tumor371225(100)146(98.65)1.04810.30590.1568
Recurrent tumor20(0)2(1.35)
Os_s0237154(69.37)83(57.24)5.12220.02360.0193
113068(30.63)62(42.76)
Rf_s0179125(64.1)54(43.2)12.6680.00040.0003
114170(35.9)71(56.8)